Member Info for smokeyjohnson108

All we know is that citadel went over the 0.5% on one date and then back below on another 0.5%. We don't know their position outside of those dates.

HelloSanDiego, the 0.1% reporting threshold is to the FCA, but isn't made public. 0.5% is the public threshold.

Sorry didn't see mact4's response.

Looks like it may have come from this conference (title in the video description)

https://www.iasusa.org/events/virtual-hiv-update-2021-los-angeles/

Manifesto, yes looks like they've not filled the country field in the last tr1. They have in some of the previous ones though (GB).

From December https://www.investegate.co.uk/synairgen-plc--sng-/rns/holding-s--in-company/202112231615016806W/

So either admin error or an indication of different ownership? Can't see how that would be.

Ndn look at Uniphar's RNSs from 2020 and you'll see Polar going over 3%. Polar purchased in the placing in SNG so went straight over 5%.

Here you go!

https://investegate.co.uk/uniphar-plc--upr-/rns/holding-s--in-company/201910111717466914P/

Ndn if you look on other shares you'll see they have issued TR1s as they went over the 3% level in the past.

I don't believe it is suspended. Says market open in a couple of places. Depending on where you're looking trades sometimes don't really show until the end of the day.

We're in P3 so the LOA to approval seems to be 61.6% for Respiratory (Table top of Page 11)

OK yep I get your points. Just hard to tell if it's just Google joining dots because of some similarity somewhere else in their index or something more relevant. Cheers.

In fact if you change the term Synairgen in that search for any big pharma you'll get that page appearing. Try "Pfizer", "Moderna", etc

BARDA funding would be great however I'm not sure that search result is a pointer to anything pending.

If you click on the vertical ellipsis next to the result you'll see why Google has included it in your results. The first point being that Google seems to have deemed the result relevant even though the search terms do not appear.

- This result seems relevant even though this search term may not appear: synairgen
- The website aspr.hhs.gov matches one or more of your search terms
- The result is in English
- This result seems relevant for this search, even though it typically appears for searches outside the United Kingdom

The primary endpoints aren't specifically to do with deaths although they'll clearly have a bearing on the results. Primary endpoints are to do with time to recovery. Deaths are a secondary endpoint.

If the seller (Polar) is rebalancing, which I think is the case then they have to finish by the end of the year.

Most peoples lungs are connected to their nose/mouth via their airways so no doubt SNG001 will still be effective as it will coat and be absorbed into the airways on the way to the lungs.

*bother

Would a blister pack of pills be any easier for them? Doubt they would both after they've read all the side effects and hazards.

Yes since it is an open label trial at this stage I guess they're not limited to waiting until any data is unblinded. Yo do wonder what the tipping point would be to stop early.

https://www.google.com/amp/s/amp.ft.com/content/a0a46dbc-ad47-11e0-a24e-00144feabdc0

That link should load the article

That article appears to be from 2011